Henan Lingrui Pharmaceutical Co Ltd (600285)

Currency in CNY
23.10
+0.07(+0.30%)
Closed·
600285 Scorecard
Full Analysis
Has raised its dividend for 6 consecutive years
600285 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
22.9123.17
52 wk Range
18.4927.26
Key Statistics
Bid/Ask
23.06 / 23.07
Prev. Close
23.1
Open
23.05
Day's Range
22.91-23.17
52 wk Range
18.49-27.26
Volume
4.56M
Average Volume (3m)
6.75M
1-Year Change
-0.13%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600285 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
23.20
Upside
+0.43%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Henan Lingrui Pharmaceutical Co Ltd Company Profile

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering various product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

Employees
2435
Market
China

Compare 600285 to Peers and Sector

Metrics to compare
600285
Peers
Sector
Relationship
P/E Ratio
17.4x30.5x−0.5x
PEG Ratio
0.78−0.170.00
Price/Book
3.9x3.2x2.6x
Price / LTM Sales
3.6x4.9x3.3x
Upside (Analyst Target)
0.4%15.0%43.4%
Fair Value Upside
Unlock4.8%7.1%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 23.20
(+0.43% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.33%
Dividend Yield
3.90%
Industry Median 1.51%
Annualised payout
0.90
Paid annually
5-Years Growth
+24.57%
Growth Streak

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
0.38 / --
Revenue / Forecast
1.02B / --
EPS Revisions
Last 90 days

600285 Income Statement

FAQ

What Stock Exchange Does Henan Lingrui Pharm Trade On?

Henan Lingrui Pharm is listed and trades on the Shanghai Stock Exchange stock exchange.

What Is the Stock Symbol for Henan Lingrui Pharm?

The stock symbol for Henan Lingrui Pharm is "600285."

What Is the Henan Lingrui Pharm Market Cap?

As of today, Henan Lingrui Pharm market cap is 13.01B.

What Is Henan Lingrui Pharm's Earnings Per Share (TTM)?

The Henan Lingrui Pharm EPS (TTM) is 1.33.

When Is the Next Henan Lingrui Pharm Earnings Date?

Henan Lingrui Pharm will release its next earnings report on 23 Oct 2025.

From a Technical Analysis Perspective, Is 600285 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Henan Lingrui Pharm Stock Split?

Henan Lingrui Pharm has split 4 times.

How Many Employees Does Henan Lingrui Pharm Have?

Henan Lingrui Pharm has 2435 employees.

What is the current trading status of Henan Lingrui Pharm (600285)?

As of 10 Aug 2025, Henan Lingrui Pharm (600285) is trading at a price of 23.10, with a previous close of 23.10. The stock has fluctuated within a day range of 22.91 to 23.17, while its 52-week range spans from 18.49 to 27.26.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.